Here are the 424B prospectus supplements from Centuri Holdings, Inc. (CTRI) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow CTRI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CTRI filings page.
Centuri Holdings, Inc. launched a primary offering of 7,441,860 shares of common stock at $21.50 per share, with gross proceeds of $159,999,990 and estimated net proceeds of $153,599,990.40 from this tranche. The company also agreed to sell 3,488,372 shares to Icahn-affiliated investors in a concurrent private placement at the same price.
The underwriters have a 30-day option to purchase up to 1,116,279 additional shares. Centuri estimates combined net proceeds of approximately $228.1 million from the offering and private placement (or $251.1 million if the option is fully exercised). The company plans to use proceeds for general corporate purposes, including acquisitions such as the announced CAUS deal, and to repay borrowings under its credit agreement. Affiliates of certain underwriters are lenders and may receive a portion of the proceeds, and the transaction is being conducted in compliance with FINRA Rule 5121.
Shares outstanding were 88,649,154 as of November 11, 2025; following the offering and private placement, the company expects 99,579,386 shares outstanding (or 100,695,665 if the option is fully exercised).
Centuri Holdings (CTRI) launched a primary offering of up to $160,000,000 of common stock under its effective shelf, with an underwriters’ option for up to an additional $24,000,000. The company also agreed to a concurrent private placement of approximately $75 million of common stock to Icahn Partners LP and Icahn Partners Master Fund LP at the public offering price, to occur immediately after this offering closes.
Centuri plans to use net proceeds for general corporate purposes, including potential acquisitions such as the CAUS Acquisition, and repayment of borrowings under its credit agreement. As of November 11, 2025, borrowings outstanding were $95.6 million on the revolving credit facility and $800.0 million on the term loan. Affiliates of certain underwriters are lenders under that facility and may receive a portion of proceeds, triggering FINRA Rule 5121 conflicts-of-interest disclosures. Shares outstanding were 88,649,154 as of November 11, 2025.